In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Novel Oral Anticoagulants for Atrial Fibrillation

EHRA Practical Guide to NOAC Use in AF

Stroke Prevention
Atrial Fibrillation
Cardiovascular Pharmacotherapy
Arrhythmias and Device Therapy

Welcome to the page that accompanies the EHRA Practical Guide on the use of novel oral anticoagulant drugs (NOACs) in patients with non-valvular atrial fibrillation (AF). This page contains resources that may be of help in your daily practice, like the proposed universal NOAC patient card, links to the AF guideline text and the practical guide itself, as well as links to a slide set and a key-messages booklet of the practical guide. 

On behalf of EHRA and the writing committee,
Jan Steffel and Hein Heidbuchel

2021 Practical Guide Documents and Products

The 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation:


Patient Cards

Patient cards are downloadable and ready for print.

Other languages

EHRA Key Message App

Access the EHRA Practical Guide to NOAC Use in AF on the Key Message App.

ESC Guidelines on Atrial Fibrillation

Access the ESC guidelines on atrial fibrillation.